Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARISE study: ARTCEREB cerebrospinal fluid refill test in CSF hypovolemia
jRCTs061250079Recruiting
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of artificial cerebrospinal fluid in idiopathic intracranial hypotension (SIH). Primary endpoint: Change in orthostatic subjective symptom scores. Started Jan 2026; status: recruiting.
02
Drugs
artificial cerebrospinal fluid
03
Conditions
idiopathic intracranial hypotension (SIH)
Beyond the preview
Go deeper on jRCTs061250079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061250079.